SavedAdd your journal

Journals / The Journal of Pediatric Research / 2020 / Cilt: 7 - Sayı: 2

The Neurodevelopmental Outcome of Severe Neonatal Hemolytic and Nonhemolytic Hyperbilirubinemia

Rüya ÇOLAK
Şebnem ÇALKAVUR
Ezgi YANGIN ERGON
Kıymet ÇELİK
Senem ALKAN ÖZDEMİR
Özgür OLUKMAN
Zeynep ÜSTÜNYURT
Pages
152–157
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

We believethat larger case series studies are needed to discuss the relationship between subgroup nonconformity and neurodevelopmental outcomes.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: Neonatal bilirubin-induced neurologic dysfunction can present with a wide spectrum of symptoms from mild neurologic impairmentto severe acute bilirubin encephalopathy.
📊
Key Findings & Data:In this study, we aimed to determine the risk factors of unconjugated hyperbilirubinemia amonghospitalized infants with serum total bilirubin levels ≥25 mg/dL and evaluate the effects of high serum bilirubin levels due to hemolysis onneurodevelopmental outcome at postnatal between 18 and 24 months.Materials and Methods: Thirty-six term infants were enrolled in the study.
💡
Conclusion & Impact:We believethat larger case series studies are needed to discuss the relationship between subgroup nonconformity and neurodevelopmental outcomes.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

Aim: Neonatal bilirubin-induced neurologic dysfunction can present with a wide spectrum of symptoms from mild neurologic impairmentto severe acute bilirubin encephalopathy. In this study, we aimed to determine the risk factors of unconjugated hyperbilirubinemia amonghospitalized infants with serum total bilirubin levels ≥25 mg/dL and evaluate the effects of high serum bilirubin levels due to hemolysis onneurodevelopmental outcome at postnatal between 18 and 24 months.Materials and Methods: Thirty-six term infants were enrolled in the study. The patients were divided into two groups according to their conditionof either hemolytic or nonhemolytic hyperbilirubinemia. Neurodevelopmental assessment with The Bayley scale of Infant Development-II atpostnatal between 18 and 24 months was performed on all infants.Results: Fourteen infants (38.9%) were in the nonhemolytic group, while 22 (61.1%) were in the hemolytic group and there was no statisticallysignificant difference between the groups in terms of the measured mean Mental Developmental index and Psychomotor Developmental indexscores. All 4 patients who underwent exchange transfusion had subgroup incompatibility and their Psychomotor Developmental index scoreswere significantly lower (p<0.05).Conclusion: In our study, we found that subgroup incompatibility was an important risk factor for hemolytic indirect hyperbilirubinemia andthat the mean psychomotor neurodevelopmental score associated with high hyperbilirubinemia may be lower in these patients. We believethat larger case series studies are needed to discuss the relationship between subgroup nonconformity and neurodevelopmental outcomes.

🔖

Cite This Article

ÇOLAK, R., ÇALKAVUR, Ş., ERGON, E. Y., ÇELİK, K., ÖZDEMİR, S. A., OLUKMAN, Ö., ÜSTÜNYURT, Z. (2020). The Neurodevelopmental Outcome of Severe Neonatal Hemolytic and Nonhemolytic Hyperbilirubinemia. The Journal of Pediatric Research, Cilt: 7 - Sayı: 2, 152–157. https://ajindex.com/articles/362892

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Schwartz HP, Haberman BE, Ruddy RM. Hyperbilirubinemia: current guidelines and emerging therapies. Pediatr Emerg Care 2011;27:884-9
  2. Hameed NN, R Vilms, and VK Bhutani. Severe neonatal hyperbilirubinemia and adverse short-term consequences in Baghdad, Iraq. Neonatology 2011;100:57-63
  3. Kaplan M, Bromiker R, Hammerman C. Severe neonatal hyperbilirubinemia and kernicterus: are these still problems in the third millennium? Neonatology 2011;100:354-62
  4. Johnson L, Brown A, Bhutani V. BIND-A clinical score for bilirubin induced neurologic dysfunction in newborns. Pediatrics 1999;104:746-7
  5. Shapiro SM. Definition of the clinical spectrum of kernicterus and bilirubin-induced neurologic dysfunction (BIND). J Perinatol 2005;25:54
  6. Mwaniki MK, Atieno M, Lawn JE, Newton CR. Long-term neurodevelopmental outcomes after intrauterine and neonatal insults: a systematic review. Lancet 2012;379:445-52
  7. Maulik PK, Darmstadt GL. Childhood disability in low-and middle-income countries: overview of screening, prevention, services, legislation, and epidemiology. Pediatrics 2007;120:1-55
  8. Rosenbaum P, Paneth N, Leviton A,et al. A report: the definition and classification of cerebral palsy April 2006. DMCN 2007;109:8-14
  9. American Academy of Pediatrics Subcommittee on Hyperbilirubinemia. Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics 2004;114:297
  10. Bayley N. Bayley scales of infant development: Manual. 1993: PsychologicalCorporation
  11. Oncel MY, Eras Z, Uras N, Canpolat FE, Erdeve O, Oguz SS. Neurodevelopmental outcomes of preterm infants treated with oral paracetamol versus ibuprofen for patent ductus arteriosus. Am J Perinatol 2017;34:1185-9
  12. Chen WX, VC Wong, KY Wong, Neurodevelopmental outcome of severe neonatal hemolytic hyperbilirubinemia. J Child Neurol 2006;21:474-9
  13. Behjati SH, Sagheb S, Aryasepehr S, Yaghmai B. Adverse events associated with neonatal exchange transfusion for hyperbilirubinemia. Indian J Pediatr 2009;76:83-5
  14. Annagür A, Altunhan H, Konak M, Koç H, Örs R. Role of subgroup incompatibility in newborn jaundice requiring exchange transfusion. Electron J Gen Med 2014;11
  15. Orgun A, Çalkavur Ş, Özgür Olukman LT, et al. Role of minor erythrocyte antigens on alloimmunızation in neonatal indirect hyperbilirubinemia background. Turk Pediatri Ars 2013;48:23-30
  16. Yvonne Wu, Kuzniewicz MW, Wickremasinghe AC, et al. Risk for cerebral palsy in infants with total serum bilirub